News

April 20, 2018April 20, 2018

#AAN2018 – Vaccination Did Not Trigger Myasthenia Gravis in Children, Study Finds

News

Vaccination does not trigger autoimmunity linked to myasthenia gravis in pediatric patients, a study based on records of the U.S. Department of Health and Human Services suggests. The findings ... Read more

April 17, 2018April 20, 2018

#AAN2018- Ra Pharma’s Myasthenia Gravis Therapy Shows Promise in Phase 1 Trial with Healthy Volunteers

News

Ra Pharma’s RA101495, a potential treatment for generalized myasthenia gravis patients, showed preliminary signs of halting red blood cells destruction in healthy volunteers, results of an early clinical trial show — ... Read more

April 13, 2018April 12, 2018

NIH Agency Pioneers Collaborative Research into Rare Diseases

News

A little-known government entity within the National Institutes of Health (NIH) is helping to lead U.S. efforts to speed up the development of therapies for some 7,000 rare diseases. ... Read more

April 12, 2018April 12, 2018

Viral Infection Could Be Contributing Factor for Myasthenia Gravis, Study Says

News

Infection of the thymus by the virus that causes fifth disease — the human parvovirus B19 — can induce thymus overgrowth (hyperplasia) contributing to the development of myasthenia gravis, researchers ... Read more

April 10, 2018April 10, 2018

Treatment for LEMS Can Benefit Myasthenia Gravis Patients, Study Reports

News

A therapy that European regulators approved for treating Lambert-Eaton myasthenic syndrome (LEMS) can help manage myasthenia gravis symptoms, a study reports. The findings on Firdapse appeared in the Journal of Clinical ... Read more

April 5, 2018April 5, 2018

Video-Assisted Thoracic Surgery Safe and Effective Method for Thymoma Removal, Study Finds

News

Researchers have determined that video-assisted thoracic surgery to remove a thymoma — a tumor in the thymus — is a safe and effective surgical method. The study, “Video-assisted thoracic ... Read more

April 3, 2018April 3, 2018

Cannabinoids May Improve Muscle Function in Myasthenia Gravis, Mouse Study Suggests

News

Treatment with cannabinoids improved muscle function in a mouse model of myasthenia gravis (MG), suggesting they may have therapeutic potential for the disease, researchers say. The study, “Cannabinoid-induced increase of quantal ... Read more

March 29, 2018March 29, 2018

Argenx’s Myasthenia Gravis Therapy Receives Orphan Drug Status in Europe

News

The European Commission has granted orphan drug status to argenx’s myasthenia gravis therapy ARGX-113 (efgartigimod), which is designed to rein in the overproduction of antibodies that damage junctions of nerve ... Read more

March 27, 2018March 27, 2018

GTP-004 Seen to Reduce Side Effects of MG Therapy Mestinon in Small Phase 1 Trial

News

Results of a Phase 1 clinical trial showed that the investigational therapy GTP-004 significantly reduced the side effects associated with the myasthenia gravis (MG) medication Mestinon (pyridostigmine). GT Biopharma, the ... Read more

March 22, 2018March 22, 2018

Myasthenia Gravis Patients Appear to Have Lower Vitamin D Levels, Study Confirms

News

Myasthenia gravis patients appear to have lower levels of vitamin D than the general population, a study confirmed. The confirmation suggested that doctors need to monitor patients’ vitamin D ... Read more

Pin It on Pinterest